November 21, 2021
Buenos Aires, Nov 19 (EFE) .- Several emerging companies in the biotechnology sector presented the potential of their projects in a virtual meeting in Argentina, in which the 2019 Nobel Prize in Economics, Michael Kremer, emphasized the need that the innovation achieves a positive economic and social impact.
Organized by the Argentine Chamber of Biotechnology (CAB), the eighth edition of BioArgentina featured the participation of the award-winning American economist and representatives of innovative startups with global impact that are emerging in Argentina.
As reported by the CAB in a statement, the meeting, held this Thursday, was also attended by the Minister of Science, Technology and Innovation of Argentina, Daniel Filmus.
In the first part of the event, the director of mAbxience, Esteban Corley, presented the lecture by Michael Kremer, professor and director of the Laboratory of Innovation for Development at the University of Chicago.
Kremer emphasized a broad definition of the concept of innovation, encompassing not only technologies, but also policies and new tools.
In this context, Kremer highlighted initiatives in which those he has worked linked to combat inequality and poverty, such as devices for water treatment in Africa or digital agriculture systems.
“Innovation leads to economic growth, it can promote global health and fight poverty, but the speed and access to this depends on social institutions,” he said.
RISING STARS IN BIOTECHNOLOGY
BioTecnología 2021 dedicated a good part of its program to the presentation of nine Argentine biotech startups that are standing out in the entrepreneurial ecosystem.
Published in Finance